12/05/2022
New research from India shows Lu177 and Ac225 PSMA based targeted radionuclide therapies can help patients with metastatic castration resistant prostate cancer
Therapeutic Nuclear Medicine Services
Delhi, DL, India
Delhi
110001
Be the first to know and let us send you an email when Nuclear Medicine Therapy India posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.